BIM
RGNX icon

BlackRock Investment Management’s Regenxbio RGNX Stock Holding History

BlackRock Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.56M Buy
83,888
+245
+0.3% +$4.68K ﹤0.01% 2391
2016
Q3 		$1.17M Sell
83,643
-246
-0.3% -$2.71K ﹤0.01% 2562
2016
Q2 		$671K Buy
83,889
+58,288
+228% +$647K ﹤0.01% 2891
2016
Q1 		$276K Buy
25,601
+284
+1% +$3.63K ﹤0.01% 3096
2015
Q4 		$420K Buy
+25,317
New +$502K ﹤0.01% 3058

Other funds holding RGNX

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock Investment Management's RGNX Position: Q4 2016 in Review

BlackRock Investment Management increased its Regenxbio (RGNX) stake by 0.29% in Q4 2016, buying an estimated $4.68K and bringing the position to 83,888 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

BlackRock Investment Management first reported a position in RGNX in Q4 2015 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

  • BlackRock Investment Management held 83,888 shares of Regenxbio worth $1.56M as of Q4 2016.
  • BlackRock Investment Management bought 245 Regenxbio shares in Q4 2016, an estimated $4.68K.
  • Regenxbio made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2391 holding.
  • BlackRock Investment Management first reported a position in Regenxbio in Q4 2015 and has held it in 5 quarters since.
  • 78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.